FRET Probes for GPCR Activation Quantification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods fail to accurately and reliably quantify the activation state of G-protein-coupled receptors, particularly in the context of IL-8 receptor activation, which is crucial for diagnosing and treating inflammatory and cancer-related conditions, due to variability in receptor response and expression levels.
Innovation Solution
A method involving fluorescent donor and acceptor probes linked to anti-GPCR and anti-arrestin antibodies, used in super-resolution confocal fluorescence microscopy to measure the activation state of GPCRs through FRET analysis, allowing for precise quantification of receptor interactions and activation levels in human biological samples.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If standard analytical methods (ELISA, mass spectrometry) are used to determine cytokine concentration, then measurement is possible, but the results lack clear diagnostic or prognostic significance due to wide fluctuations and variability in receptor response
Solution Approach 1:
The patent replaces traditional biochemical measurement methods (ELISA, mass spectrometry) with a fluorescence resonance energy transfer (FRET) optical system. This substitution enables direct visualization and quantification of receptor activation states through fluorescent probes that change emission properties when receptors are activated, providing reliable diagnostic information that correlates with actual receptor function rather than just cytokine presence
Solution Approach 2:
The invention utilizes color/fluorescence changes as indicators of receptor activation. Donor and acceptor fluorescent probes are employed where energy transfer between them produces detectable changes in fluorescence intensity and lifetime. These optical signal changes directly reflect the activation state of GPCRs, enabling precise and reliable measurement of receptor function that has clear diagnostic significance
2Measurement precision
If fluorescent probes and FRET analysis are used to measure GPCR activation, then measurement precision is improved, but device complexity increases due to need for specialized microscopy equipment
Solution Approach 1:
The patent introduces fluorescent donor and acceptor probes as intermediary molecules that bind to the GPCR of interest. These probes act as mediators between the receptor and the detection system, converting receptor activation into measurable optical signals through FRET. This intermediary approach enables precise measurement while using relatively accessible confocal microscopy equipment rather than requiring extremely complex instrumentation
Solution Approach 2:
The invention measures changes in fluorescence lifetime and intensity as key parameters to detect receptor activation. By focusing on these optical parameter changes rather than requiring complex mechanical or chemical analysis systems, the method achieves high measurement precision with equipment that is becoming increasingly accessible in modern laboratories
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach provides a simple, cost-effective, and reliable method to quantify GPCR activation states, offering diagnostic and prognostic insights into inflammatory and cancer-related conditions by accurately measuring receptor interactions and activation levels, enhancing our understanding of IL-8 receptor activity.
Implementation Method 1
sensing the activation state of the GCPR receptors by means of fluorescence microscopy techniques, preferably super-resolution confocal fluorescence microscopy
Data Source
AI summary
A method for measurement of an activation state of G-protein-coupled receptors comprises: supplying a human biological sample; preparing a fluorescent donor probe comprising an anti-GPCR Fab fragment or antibody and a fluorophore group linked via amide bond to an amino group of the N-terminal amino acid of the light chain and/or of the N-terminal amino acid of the heavy chain of the Fab fragment or antibody; preparing a fluorescent acceptor probe comprising an anti-G-protein and/or anti-arrestin Fab fragment or antibody and a fluorophore group linked via amide bond to an amino group of the N-terminal amino acid of the light chain and/or of the N-terminal amino acid of the heavy chain of the Fab fragment or antibody; setting the human biological sample in contact with the fluorescent acceptor probe and with the fluorescent donor probe; sensing the activation state of the GCPR receptors by means of fluorescence microscopy techniques.